Modulation of functional activities of the neurotoxin from black widow spider venom  by Grishin, E.V. et al.
Volume 336, number 2,205-207 FEBS 13406 
0 1993 Federation of European Biochemical Societies 00145793/93/%6.00 
December 1993 
Modulation of functional activities of the neurotoxin from black widow 
spider venom 
E.V. Grishin”, N.H. Himmelreichb, K.A. Pluzhnikov”, N.G. 
T.M. Volkova”, P.G. Wall” 
Pozdnyakovab, L.C. Storchakb, 
“Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16110, 
117871 GSP Moscow, V-437, Russian Federation 
bPalladin Institute of Biochemistry, Ukranian Academy of Sciences, ul. Leontovich 9, Kiev 252030, Ukraine 
Received 17 September 1993 
We have studied the action of an o-latrotoxin (cz-LTX) complex of two polypeptides (LTX 130 kDa and low molecular weight protein (LMWP) 
8 kDa) and the action of a venom fraction containing LTX with excess LMWP on calcium influx into synaptosomes and PC12 cells as well as 
on [14C[GABA release from synaptosomes. Both preparations considerably activate calcium influx and stimulate [“‘C]GABA release from synap- 
tosomes. Preincubation of both preparations with antibodies against a 14 amino acid residue C-terminal peptide of LMWP differentially modulates 
these effects. Antibodies inhibit induced calcium influx and enhance induced GABA release. 
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1. INTRODUCTION 
a-Latrotoxin (a-LTX) isolated from black widow spi- 
der venom selectively binds to presynaptic nerve end- 
ings of vertebrates and stimulates massive neurotrans- 
mitter release from virtually all types of synapses [l]. 
The action of a-LTX increases membrane calcium 
permeability and subsequent ransmitter release [1,2]. 
Recently it was shown that highly purified toxin prepa- 
rations contain two components - polypeptides of 1401 
(LTX) and 70 (low molecular weight protein, LMWP) 
amino acid residues [3,4]. This study examines the func- 
tional activity of LMWP and the process of its specific 
interaction with LTX in complex. 
2. EXPERIMENTAL 
2.1. Purification of a-LTX, LMWF and LMWP 
Crude Latrodectus mactans tredecimguttatus venom was obtained 
by water extraction of fresh spider venom glands. Isolation of a-LTX 
was performed as described earlier [5]. LMWF corresponds to fraction 
S5 from gel filtration of crude venom on Sephacryl S-300 [S]. For 
isolation of LMWP, 10% trichloroacetic acid was added to LMWF 
and precipitate removed by centrifugation. Supematant was fraction- 
ated by reverse phase HPLC on an Ultrapore RPMC column (5 p, 
4.6 x 250 mm) (Beckman, USA) in 0.1% TFA with an acetonitrile 
concentration gradient. Obtained fractions were lyophilized and 
LMWP dissolved in suitable buffer. 
2.2. Generation of antibodies 
Polyclonal antibodies against synthetic peptide corresponding to 
the 57-70 C-terminal fragment of LMWP were raised in rabbits after 
*Corresponding author. Fax: (7) (095) 330 301. 
coupling to Keyhole-limpet haemocyanine by the glutaraldehyde 
method [6]. Anti-peptide antibodies (Abs) were affinity purified with 
immobilized synthetic peptide. 
2.3. Calcium influx 
Freshly prepared synaptosomes [7] were resuspended at 4 mg of 
protein/ml in standard saline medium. 45CaZ+ (0.5 mCi/ml) was added 
after 15 min preincubation at room temperature to ensure a return to 
steady-state conditions. Abs modified (1 h preincubation) or unmodi- 
fied a-LTX, LMWF or LMWP was added to synaptosomal suspen- 
sion simultaneously with 4sCa2+. Toterminate 45Ca2+ uptake at definite 
time intervals, 100 pl aliquots were layered onto Sephadex C-50 col- 
umns (1 ml bed volume) pre-equilibrated with 50 mM Tris- HCl, pH 
7.4,2 mM CaCl, and eluted with 0.8 ml of 10 mM Tris-HCl, pH 7.4, 
100 mM NaCl. Synaptosomes were solubilized in SDS (final concen- 
tration 1%) and synaptosomal 45CaZ+ was quantitated by scintillation 
counting using an aqueous cocktail in a Delta 300 counter (Tracer 
Analytic, USA). 
PC cells cultured in Eagle’s minimal essential medium (Sigma, 
USA), containing 10% horse serum (‘Vector’, Novosibirsk) and 5% 
fetal calf serum (‘Bacpreparat’, Minsk) as monolayer were detached, 
washed and resuspended in standard saline medium at 1 mg of cell 
protein/ml. 45CaZ’ influx was stopped by filtration of 0.25 ml aliquots 
through Whatman GF/C filters, which were then washed twice with 
4 ml of ice-cold buffer containing 126 mM NaCl, 5 mM KCl, 20 mM 
HEPES, pH 7.4. 
2.4. GABA release from synaptosomes 
Suspensions of synaptosomes were preloaded with [14C]GABA in 
buffer containing 10m5 M amino oxyacetate according to the described 
method [8]. After 5 min incubation at 30°C, initial levels of 
[14C]GABA were measured (zero point). Abs-modified or unmodified 
a-LTX, LMWF or LMWP were added at the zero point. At definite 
times 0.5 ml aliquots were removed and filtrated through Whatman 
GF/C filters. Before scintillation counting, pellets were solubilized in 
1% SDS. Protein recovery of synaptosomal suspension was 93-96%. 
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3. RESULTS AND DISCUSSION 
Independent of isolation method [5,9] highly purified 
cl-LTX consists of two polypeptides with m.m. 130 kDa 
(LTX) [3] and 8 kDa (LMWP) [4]. N-terminal amino 
acid sequence analysis showed that LTX and LMWP 
are present in a-LTX complex in practically equal quan- 
tity. Attempts to separate these two polypeptides in 
native conditions by different chromatographic meth- 
ods were unsuccessful. Homogeneous LMWP was pre- 
pared in this study using a low molecular weight frac- 
tion of venom (LMWF; m.m. 5-10 kDa) obtained by 
gel filtration of crude venom [5]. Purified LMWP did 
not exhibit any biological activity peculiar for ol-LTX. 
To elucidate the role of LMWP in a-LTX complex, 
rabbit polyclonal antibodies (Abs) were raised against 
synthetic peptide corresponding to a C-terminal frag- 
ment of LMWP with the structure: 
Asn-Lys-Val-Tyr-Glu-Glu-Lys-Asp-Thr-Pro-Pro-Val- 
Gln-Glu 
These Abs were highly specific to LMWP and could not 
recognize other proteins in the spider venom. Electro- 
phoretic analysis of venom and its fractions followed by 
Western blots using these Abs revealed LMWP in puri- 
fied a-LTX and in LMWF of the venom (Fig. 1). PAAG 
electrophoresis and reverse-phase HPLC chromatogra- 
phy showed that LMWF contains LMWP (about 50% 
of total protein) along with a mixture of other low mo- 
lecular weight proteins. Western blots with A4 mono- 
clonal antibodies against LTX [2] showed the presence 
of no more than 1% LTX in LMWF (Fig. 1). This could 
be accounted for by non-specific LTX binding to matrix 
during gel filtration of the crude venom on Sephacryl 
s-300. 
Previously, in studies of the modification of toxin 
effects by monoclonal antibodies against a-LTX, it was 
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Fig. 3. Calcium inllux into PC12 cells for 15 min: 1, control; 2, a-LTX 
(0.13 ,ug/ml); 3, LMWF (4 pg/ml); 4, LMWF-ABs complex (1:2 molar 
ratio). 
Fig. 1. Immunoblot detection with monoclonal antibodies A-4 (a) and 
polyclonal antibodies Abs (b) of rz-LTX (lane 1) and LMWF (lane 2). 
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Fig. 2. Effect of a-LTX (1.3 pug/ml), LMWF (40 @ml) and LMWF- 
Abs complex (1:2 molar ratio) on calcium influx into synaptosomes. 
Each point represents the mean value of duplicate assay. The figure 
shows a representative of eight experiments. 
hypothesized that a-LTX complex has separate func- 
tional sites which facilitate high affinity binding to a 
membrane receptor, toxin-induced Ca” uptake and 
toxin-stimulated neurotransmitter elease [2]. Analysis 
of functional properties of LMWF showed that this 
fraction, like a-LTX [2], activates calcium influx into 
synaptosomes and PC1 2 cells. The effects of LMWF are 
illustrated in Figs. 2 and 3. As shown, LMWF proved 
very active, but at concentration 5 x 10m7 M (4 pg/ml), 
which is much higher than concentrations of a-LTX 
which produce the same effect. Homogeneous LMWP 
was inactive in this procedure (results not shown). Ex- 
periments in which LMWF was preincubated with Abs 
before application to nerve endings exhibited substan- 
tially decreased calcium influx relative to unmodified 
LMWF. It is noteworthy that in the experiments with 
ol-LTX, a slight inhibition of induced calcium influx 
could be observed only in the case of very high excess 
of Abs. At the same time, mAbs A4 against a-LTX [2], 
which eliminates the ability of a-LTX to increase cal- 
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Fig. 4. Stimulation of [i4C]GABA release from synaptosomes by o- 
LTX (0.4 &ml), LMWF (4 &ml), LMWF-Abs complex (1:2 molar 
ratio). 
cium influx into synaptosomes, also blocks this ability 
of LMWF (data not shown). 
LMWF, but not purified LMWP, induced 
[14C]GABA release from rat synaptosomes, although 
this effect was less pronounced than in experiments with 
oz-LTX (Fig. 4). The dose-effect of LMWF on synap- 
tosome neurosecretion was investigated. LMWF at con- 
centration less then 10 @ml induces slightly detectable 
secretion, When the concentration of LMWF was in- 
creased its secretagogue action became more pro- 
nounced. Surprisingly, the effect of LMWF-Abs com- 
plex on [14C]GABA release was significantly enhanced, 
relative to unmofidied LMWF, to levels approximately 
equivalent o those induced by a-LTX (Fig. 4). 
In spite of the absence of direct results in this study 
with LTX free from LMWP or with LMWP free from 
LTX, one can assume that LMWP contributes to secre- 
tagogue and ionophore actions of purified a-LTX. The 
enhanced effectiveness against calcium influx and the 
stimulation of secretagogue activity by antibodies 
against the C-terminal fragment of LMWP in experi- 
ments with LMWF, which is enriched in LMWP rela- 
tive to LTX, suggests that an understanding of the rela- 
tionship between LTX and LMWP will be possible only 
with experiments using expressed LTX and LMWP 
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